NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

about

Just Missing the Mark: Discharging High-risk Atrial Fibrillation / Flutter without Thromboprophylaxis.

P2860

Q55101940-6BD3E043-F851-4BD3-9907-37A20F3A6E49

P2860

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

Item

http://www.wikidata.org/entity/Q41524034

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

@en

type

Item

label

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

@en

prefLabel

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

@en

P1476

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

@en

P2093

Jheel Pandya

http://www.w3.org/2001/XMLSchema#string

Madeline Goldberg

http://www.w3.org/2001/XMLSchema#string

Priya Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation

New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?

Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries.

NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis

Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.

Atrial fibrillation and stroke: epidemiology.

P304

e1395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7759/CUREUS.1395

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28845374

http://www.w3.org/2001/XMLSchema#string

P932

5572042

http://www.w3.org/2001/XMLSchema#string

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

about

P2860

P2860

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932